Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Softcare Limited ( (HK:2698) ) just unveiled an update.
Softcare Limited has scheduled a board meeting for 20 March 2026 to review and approve the audited annual results for the year ended 31 December 2025, and to authorise their publication. The board will also consider whether to recommend a final dividend, a decision that could affect shareholder returns and signal the company’s confidence in its financial performance.
The announcement also reconfirms the current composition of Softcare’s board, listing its executive, non-executive and independent non-executive directors as of 6 March 2026. This disclosure underscores the company’s corporate governance structure ahead of its upcoming results decision, offering investors clarity on the leadership responsible for financial oversight.
The most recent analyst rating on (HK:2698) stock is a Buy with a HK$41.00 price target. To see the full list of analyst forecasts on Softcare Limited stock, see the HK:2698 Stock Forecast page.
More about Softcare Limited
Softcare Limited, incorporated in the Cayman Islands and listed in Hong Kong under stock code 2698, operates through a board comprising executive, non-executive and independent non-executive directors. The company is governed from Hong Kong, where its chairman, Shen Yanchang, leads oversight of its corporate and financial reporting activities, including results announcements and dividend considerations.
Average Trading Volume: 671,954
Current Market Cap: HK$17.39B
For a thorough assessment of 2698 stock, go to TipRanks’ Stock Analysis page.